Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | SVP, Chief Medical Officer | $874K | Feb 2, 2022 | ||
NUVL | Nuvalent, Inc. | Director | $206K | Jun 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|